Eugene Chan's guest appearances

Eugene Chan

Letter To Hong Kong

Empowered Patient Podcast

Talk Human To Me

Yes EuCan

Joseph Lee

David Wong

Konda Mason

Jenn Lim

Susie Wyshak

Mia Birdsong

Emily Lau

Paul Chan

Mohammad Modarres

Molly Hayward

Wayne Sutton

Todd Lieman

Albert Ho

Anna Wu

Kevin Yeung

OwlTail

Eugene Chan Abpro

 Dr. Eugene Chan, Chairman and Co-Founder of Abpro, talks about the next generation of antibody therapies that can target more than one target to activate the immune system in the fight against cancer. Abpro is also working on a prophylactic antibody therapy to help prevent immunocompromised patients from getting COVID. Eugene explains, "Abpro has developed the antibodies, in a lot of these cases, to be able to target more than one target. This basically activates the immune system more so that whatever you're targeting is cleared more rapidly from the body. This applies to the cases of cancer that we are focused on, and we've basically developed these antibodies called bispecific antibodies - bi for targeting two different sites. These antibodies essentially have more and greater activity than conventional antibodies." "We developed a program and antibodies that bind to HER2+, which is one of the molecular markers on breast and gastric cancers. This particular therapy brings the immune system, the body's own natural immune system, to these cancer cells in a very active manner, which then allows it to get cleared from the body much sooner than the other mono-specific therapies that are currently out there." "Monoclonal antibodies are the body's own natural defense system for a lot of diseases. The ability to take these and augment and make them better is really the way to go because, ultimately, the body is already accustomed to these types of molecules. So we know to some degree they're safe. When compared to things like chemotherapy or even radiotherapy, these things are going to be much safer because they naturally exist in some way, shape or form in the body when you're fighting a disease or when your body's exposed to a new antigen or some sort of new threat. We're taking this approach and enhancing the body's ability to fight cancer and infection by augmenting the structure of these molecules." #Abpro #Antibodies #MonoclonalAntibodies #Cancer #Tumors #COVID #HER2+ abpro.com Download the transcript here

Dr. Eugene Chan, Chairman and Co-Founder of Abpro, talks about the next generation of antibody therapies that can target more than one target to activate the immune system in the fight against cancer. Abpro is also working on a prophylactic antibody therapy to help prevent immunocompromised patients from getting COVID. Eugene explains, "Abpro has developed the antibodies, in a lot of these cases, to be able to target more than one target. This basically activates the immune system more so that whatever you're targeting is cleared more rapidly from the body. This applies to the cases of cancer that we are focused on, and we've basically developed these antibodies called bispecific antibodies - bi for targeting two different sites. These antibodies essentially have more and greater activity than conventional antibodies." "We developed a program and antibodies that bind to HER2+, which is one of the molecular markers on breast and gastric cancers. This particular therapy brings the immune system, the body's own natural immune system, to these cancer cells in a very active manner, which then allows it to get cleared from the body much sooner than the other mono-specific therapies that are currently out there." "Monoclonal antibodies are the body's own natural defense system for a lot of diseases. The ability to take these and augment and make them better is really the way to go because, ultimately, the body is already accustomed to these types of molecules. So we know to some degree they're safe. When compared to things like chemotherapy or even radiotherapy, these things are going to be much safer because they naturally exist in some way, shape or form in the body when you're fighting a disease or when your body's exposed to a new antigen or some sort of new threat. We're taking this approach and enhancing the body's ability to fight cancer and infection by augmenting the structure of these molecules." #Abpro #Antibodies #MonoclonalAntibodies #Cancer #Tumors #COVID #HER2+ <a href="http://abpro.com" rel="noopener nofollow" target="_blank">abpro.com</a> <a href="http://empoweredpatientradio.com/platform-to-develop-next-generation-antibodies-with-two-binding-sites-to-treat-her2-related-cancer-and-covid-with-dr-eugene-chan-abpro-transcript" rel="noopener nofollow" target="_blank">Download the transcript here</a>

Platform to Develop Next Generation Antibodies with Two Binding Sites to Treat HER2+ Related Cancer and COVID with Dr. Eugene Chan Abpro

Dear fellow Hongkongers, Hong Kong is my home, and it is also your home. I was born, and brought up in a middle-class family in Hong Kong.   I truly love Hong Kong and have lived here all my life. I was fortunate enough to have been able to go abro...

Dear fellow Hongkongers,   Hong Kong is my home, and it is also your home.   I was born, and brought up in a middle-class family in Hong Kong.   I truly love Hong Kong and have lived here all my life. I was fortunate enough to have been able to go abro...

Dr Eugene Chan, President of the Association of Hong Kong Professionals

"Show up, and be your best self." - Eugene Chan sits down to talk human to me about family, technology, happiness, art, kindness, and duty. | Talk Human To Me is a podcast for entrepeneurs, that has nothing to do with entrepreneurship. Listen in as we talk with doers, makers, &amp; creators about other thoughts that complete them as humans.

"Show up, and be your best self." - Eugene Chan sits down to talk human to me about family, technology, happiness, art, kindness, and duty. | Talk Human To Me is a podcast for entrepeneurs, that has nothing to do with entrepreneurship. Listen in as we talk with doers, makers, &amp; creators about other thoughts that complete them as humans.

Eugene Chan Talks Human About Being a Parent